Does Graves' disease during puberty influence adult bone mineral density?

被引:3
作者
Radetti, G
Bona, G
Corrias, A
Cappa, M
DeSanctis, V
Lauriola, S
Paganini, C
Rigon, F
机构
[1] Reg Hosp, Dept Pediat, I-39100 Bolzano, Italy
[2] Univ Novara, Pediat Unit, Novara, Italy
[3] Osped Regina Margherita, Dept Pediat Endocrinol, Turin, Italy
[4] IRCCS, Bambino Gesu Childrens Hosp, Auxol Unit, Palidoro, Italy
[5] St Anna Hosp, Dept Pediat, Ferrara, Italy
[6] Univ Verona, Pediat Unit, I-37100 Verona, Italy
[7] Univ Padua, Pediat Unit, I-35100 Padua, Italy
关键词
Graves' disease; bone mineral density; dual-energy X-ray absorptiometry; antithyroid treatment;
D O I
10.1159/000065491
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To evaluate the bone mineral density at lumbar spine and at femoral neck in a group of young adults in whom Graves' disease developed during childhood and adolescence. Patients and Methods: We examined 28 patients (5 male, 23 female, age 20.9 +/- 3.3 years) who were 11.8 +/- 2.9 years old at the onset of Graves' disease. They were treated either with methimazole (14 patients) or with methimazole plus l-thyroxine (14 patients). At the time of the investigation, 13 patients were considered cured following antithyroid treatment, 2 were still on antithyroid drugs, 3 were on replacement therapy with l-thyroxine because of hypothyroidism, and 10, treated either surgically or with I-131, were on replacement therapy. The bone mineral density was measured at the lumbar spine (L2-L4) and at the femoral neck, using dual-energy X-ray absorptiometry. Results: The spinal bone mineral density SD score was -0.28 +/- 1.02, the femoral neck bone mineral density SD score was 0.36 +/- 1.02, and both were not different from zero (NS). We did not find any correlation between the bone mineral density of the femoral neck and that of the lumbar spine and the clinical parameters. Conclusion: Graves' disease, beginning in childhood and adolescence, when appropriately treated, does not affect attainment of peak bone mass. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:176 / 179
页数:4
相关论文
共 14 条
[1]  
ADAMI S, 1995, J BONE MINER RES, V10, P511
[2]  
BONJOUR JP, 1994, OSTEOPOROSIS INT, V4, P7
[3]   Standardization of BMD measurements [J].
Formica, CA .
OSTEOPOROSIS INTERNATIONAL, 1998, 8 (01) :1-3
[4]   Role of growth hormone and sex steroids in achieving and maintaining normal bone mass [J].
Holmes, SJ ;
Shalet, SM .
HORMONE RESEARCH, 1996, 45 (1-2) :86-93
[5]  
Langdahl BL, 1996, THYROID, V6, P161
[6]   Reduced bone mineral density at diagnosis and bone mineral recovery during treatment in children with Graves' disease [J].
Lucidarme, N ;
Ruiz, JC ;
Czernichow, P ;
Léger, J .
JOURNAL OF PEDIATRICS, 2000, 137 (01) :56-62
[7]   TIMING OF PEAK BONE MASS IN CAUCASIAN FEMALES AND ITS IMPLICATION FOR THE PREVENTION OF OSTEOPOROSIS - INFERENCE FROM A CROSS-SECTIONAL MODEL [J].
MATKOVIC, V ;
JELIC, T ;
WARDLAW, GM ;
ILICH, JZ ;
GOEL, PK ;
WRIGHT, JK ;
ANDON, MB ;
SMITH, KT ;
HEANEY, RP .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (02) :799-808
[8]  
MELSEN F, 1977, ACTA PATH MICRO IM A, V85, P141
[9]   Longitudinal changes of bone density and bone resorption in hyperthyroid girls during treatment [J].
Mora, S ;
Weber, G ;
Marenzi, K ;
Signorini, E ;
Rovelli, R ;
Proverbio, MC ;
Chiumello, G .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (11) :1971-1977
[10]   EFFECTS OF THYROID-HORMONES ON BONE AND MINERAL METABOLISM [J].
MOSEKILDE, L ;
ERIKSEN, EF ;
CHARLES, P .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1990, 19 (01) :35-63